BRAF and central nervous system cancer: In other LEATs, the BRAF mutation has been observed in 30-51% of DNTs [13, 15, 16] and in 3/10 of the recently described polymorphous low-grade neuroepithelial tumours of the young (PLNTY) [17], but not in multinodular and vacuolating neuronal tumours (MVNT) [18] and angiocentric gliomas [19].